SHH · 603538.SS
Ningbo Menovo Pharmaceutical Co., Ltd.
CN¥21.32+CN¥1.04 (+5.13%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.6% below the high.
Loading market information…
SHH · 603998.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Hunan Fangsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Hunan Fangsheng Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.40 per share, paid semi-annual. The forward yield is 3.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Hunan Fangsheng Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hunan Fangsheng Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating within China, Hunan Fangsheng Pharmaceutical Co., Ltd. is engaged in the complete spectrum of pharmaceutical activities, from research and development to manufacturing and sales. Its diverse product line encompasses tablets, capsules, and granules, addressing a wide array of therapeutic areas such as cardiovascular, cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infective conditions. The company was established in 2002 and is headquartered in Changsha, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥429.53M |
| Q3 2024 | Oct 28, 2024 | CN¥0.21 | CN¥438.00M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥21.32+CN¥1.04 (+5.13%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.6% below the high.
CN¥16.01+CN¥0.22 (+1.39%)
Changchun BCHT Biotechnology Co.’s quoted price sits in the lower half of its reported 52-week range, 34.57% below the high.
CN¥10.61+CN¥0.37 (+3.61%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.43% below the high.
CN¥8.79+CN¥0.23 (+2.69%)
HPGC Renmintongtai Pharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 51.52% below the high.
CN¥7.26+CN¥0.16 (+2.25%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 2.55% below the high.
CN¥3.63+CN¥0.08 (+2.25%)
Fuan Pharmaceutical (Group) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.4% below the high.
CN¥26.60+CN¥0.34 (+1.29%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.85% below the high.
CN¥12.72+CN¥0.17 (+1.35%)
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.49% below the high.
